For Fulcrum Therapeutics, the modeled fair value has been reset from about US$19.00 to roughly US$5.43, a cut of around 71% ...

CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically ...

The group created no revenue during the period as it continued to develop its portfolio of assets in Canada.

Fulcrum Therapeutics will lay off the majority of its workforce after it said it would terminate the development of a sickle-cell-disease treatment. The company on Thursday said it expects to reduce ...

Fulcrum Therapeutics Inc. (NASDAQ: FULC) stock is surging on Monday, after the company released initial results from the ongoing 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle ...

・Piper Sandler boosted its target price to $23 per share from $16. ・Wainwright increased its price target to $25 from $18, noting a clear dose-response in fetal hemoglobin (HbF) and a strong ...

― Decision follows FDA feedback regarding the implications of the secondary malignancies observed with Tazverik ® (tazemetostat) and the product’s subsequent global withdrawal on the benefit-risk ...

Since the aughts, sustainable aviation fuel makers, which include Neste in Finland and World Energy in the U.S., have grown the industry into a $433 million global market. The aviation sector accounts ...

Fulcrum Bioenergy has declared bankruptcy, and a Gary environmental group is pleased by the news. The California-based company filed for Chapter 11 bankruptcy Sept. 9, according to a District of ...

The settlement terms remain undisclosed, though one brother has already disappeared from Fulcrum Development’s website.